Clinical Trials

Synthetic Genomics and Advaxis announced that they have completed development and deployment of the first current good manufacturing practice (cGMP) synthetic biology facility for the…
Read More...

Hovione announced that it will soon initiate recruitment for its Phase 1 clinical trial of HY02. This first in human study is a double-blinded, randomized trial, which will include…
Read More...

X4 Pharmaceuticals announced dosing of the first patient in the Phase 2 portion of the ongoing Phase 1/2 study evaluating X4P-001, the CXCR4 inhibitor, in combination with Inlyta…
Read More...

TrialScope has announced the launch its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform self-assessments of their disclosure practices. The…
Read More...

Atox Bio announced that Reltecimod (previously AB103) successfully completed pre-specified futility analysis in patients with Necrotizing Soft Tissue Infections and will continue…
Read More...

Debiopharm International SA and ImmunoGen announced that Debiopharm has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC (antibody-drug conjugates) for the…
Read More...

Worldwide Clinical Trials has appointed Karen Nowatkoski as Vice President of Clinical Operations and Site Management. She will oversee and provide global management for the team of…
Read More...

PCI Biotech and RXi Pharmaceuticals announced that they are extending their preclinical research collaboration initiated on April 7, 2015. The preclinical research collaboration will…
Read More...

Sanofi announced that the CHMP (Committee for Medicinal Products for Human Use) of the EMA (European Medicines Agency) recommended the use of Insulin lispro Sanofi (insulin lispro 100…
Read More...

Pharmaceutical Product Development (PPD) has expanded its vaccine sciences lab in Richmond, Virginia, to enhance its ability so as to provide industry-leading capabilities to meet…
Read More...

Aduro Biotech announced the expansion of its clinical collaboration with Merck to include an additional Phase 2 clinical trial to evaluate the combination of CRS-207, Aduro’s LADD…
Read More...

Kemwell Biopharma announced that it has manufactured and supplied drug substance using its state-of-the-art mammalian cell culture plant in India for clinical trials that will be…
Read More...

Acasti Pharma announced that it has received an invitation to present the CaPre (omega-3 phospholipid) study results at the National Lipid Association Scientific Sessions in…
Read More...

Concert Pharmaceuticals received notice from the U.S. FDA that its CTP-543 Phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA had previously…
Read More...

CytoDyn In. announced the treatment of the first patient suffering from GvHD(Graft versus Host Disease) with use of PRO 140 during its clinical trial Phase 2. The multicenter,…
Read More...

DelMar Pharmaceuticals  announced that it has signed collaboration agreement with PRA Health Sciences for company's Phase 3 trial of VAL-083 in recurrent glioblastoma multiforme (GBM).…
Read More...

Biogen has acquired Remedy Pharmaceuticals’ Phase 3 candidate CIRARA (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of…
Read More...

NantCell and NantKwest announced that the FDA has authorized NANT Cancer Vaccine for clinical trial enrollment (ClinicalTrials.gov NCT03136406). The NANT Cancer Vaccine is the first…
Read More...

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...

Teva Pharmaceutical and Active Biotech announced that the results from the CONCERTO trial did not meet primary endpoint. The trial was based on patients with relapsing-remitting…
Read More...